Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Published:2009-07 Issue:7 Volume:26 Page:607-611
ISSN:1091-4269
Container-title:Depression and Anxiety
language:en
Short-container-title:Depress. Anxiety

Author:

Akhondzadeh Shahin,Jafari Sara,Raisi Firoozeh,Nasehi Abbas Ali,Ghoreishi Aboulfazl,Salehi Bahman,Mohebbi-Rasa Soodeh,Raznahan Maedeh,Kamalipour Abbas

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/da.20589/fullpdf

Reference28 articles.

1. Major depression: emerging therapeutics;Sen;Mt Sinai J Med,2008

2. The future of depression psychopharmacology;Belmaker;CNS Spectr,2008

3. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs;Millan;Neurotherapeutics,2009

4. Achieving remission and favorable outcomes in patients with depression/anxiety and substance use disorders;Schatzberg;CNS Spectr,2008

5. Treating depression to full remission;Trivedi;J Clin Psychiatry,2009

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo;Brain, Behavior, and Immunity;2025-01

2. The inflammatory underpinning of depression: An historical perspective;Brain, Behavior, and Immunity;2024-11

3. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression;Pharmacological Research;2024-09

4. Cyclooxygenase-2 inhibitors alleviated depressive and anxious-like behaviors in mice exposed to lipopolysaccharide: Involvement of oxidative stress and neuroinflammation;Pharmacology Biochemistry and Behavior;2024-07

5. Immune cell markers associated with early life major depressive episodes;Journal of Mood & Anxiety Disorders;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3